Treatment of nephrotic syndrome with adrenocorticotropic hormone (ACTH) gel

Drug Design, Development and Therapy

Volumn , Issue 5, 2011, Pages 147-153

  Bomback, Andrew S ^a   Tumlin, James A ^b   Baranski, Joel ^c   Bourdeau, James E ^d   Besarab, Anatole ^e   Appel, Alice S ^a   Radhakrishnan, Jai ^a   Appel, Gerald B ^a  

^a Columbia University College of Physicians and Surgeons ^*  (United States)

^b UNIVERSITY OF TENNESSEE COLLEGE OF MEDICINE   (United States)

^c Transplant Services   (United States)

^d Urologic Specialists of Oklahoma   (United States)

^e HENRY FORD HEALTH SYSTEM   (United States)

Author keywords

Chronic kidney disease; Membranous nephropathy; Nephrotic syndrome

Indexed keywords

CORTICOTROPIN; HP ACTHAR; PROTEIN; UNCLASSIFIED DRUG;

ACUTE KIDNEY FAILURE; ADULT; AGED; ARTICLE; BONE DEMINERALIZATION; CLINICAL ARTICLE; CREATININE URINE LEVEL; DRUG MECHANISM; DRUG RESPONSE; DRUG WITHDRAWAL; FEMALE; FOCAL GLOMERULOSCLEROSIS; FOLLOW UP; GEL; HUMAN; HYPERGLYCEMIA; IDIOPATHIC DISEASE; IMMUNOGLOBULIN A NEPHROPATHY; IMPAIRED GLUCOSE TOLERANCE; INFECTION; KIDNEY FUNCTION; LIPOID NEPHROSIS; MALE; MEMBRANOUS GLOMERULONEPHRITIS; NEPHROTIC SYNDROME; OSTEOLYSIS; PROLIFERATIVE GLOMERULONEPHRITIS; PROTEIN URINE LEVEL; PROTEINURIA; RELAPSE; REMISSION; RETROSPECTIVE STUDY; SIDE EFFECT; SYSTEMIC LUPUS ERYTHEMATOSUS; TREATMENT DURATION; UNITED STATES; WEIGHT GAIN; CASE REPORT; GLOMERULUS FILTRATION RATE; MIDDLE AGED; PATHOPHYSIOLOGY; PHYSIOLOGY; TREATMENT OUTCOME; URINE;

ADRENOCORTICOTROPIC HORMONE; ADULT; AGED; AGED, 80 AND OVER; FEMALE; GELS; GLOMERULAR FILTRATION RATE; HUMANS; MALE; MIDDLE AGED; NEPHROTIC SYNDROME; PROTEINURIA; REMISSION INDUCTION; RETROSPECTIVE STUDIES; TREATMENT OUTCOME; YOUNG ADULT;

EID: 79952959947     PISSN: 11778881     EISSN: None     Source Type: Journal    
DOI: 10.2147/DDDT.S17521     Document Type: Article

References (13)

1. Waldman M, Crew RJ, Valeri A, et al. Adult minimal-change disease: clinical characteristics, treatment, and outcomes. Clin J Am Soc Nephrol. 2007;2:445-453.
2. Palmer SC, Nand K, Strippoli GF. Interventions for minimal change disease in adults with nephrotic syndrome. Cochrane Database Syst Rev. 2008:CD001537.
3. Ponticelli C, Edefonti A, Ghio L, et al. Cyclosporin versus cyclophosphamide for patients with steroid-dependent and frequently relapsing idiopathic nephrotic syndrome: a multicentre randomized controlled trial. Nephrol Dial Transplant. 1993;8:1326-1332.
4. Cattran DC, Appel GB, Hebert LA, et al. Cyclosporine in patients with steroid-resistant membranous nephropathy: a randomized trial. Kidney Int. 2001;59:1484-1490.
5. Cattran DC, Alexopoulos E, Heering P, et al. Cyclosporin in idiopathic glomerular disease associated with the nephrotic syndrome: workshop recommendations. Kidney Int. 2007;72:1429-1447.
6. Segarra A, Praga M, Ramos N, et al. Successful treatment of membranous glomerulonephritis with rituximab in calcineurin inhibitordependent patients. Clin J Am Soc Nephrol. 2009;4:1083-1088.
7. Cattran DC, Wang MM, Appel G, Matalon A, Briggs W. Mycophenolate mofetil in the treatment of focal segmental glomerulosclerosis. Clin Nephrol. 2004;62:405-411.
8. Cattran DC, Appel GB, Hebert LA, et al. A randomized trial of cyclosporine in patients with steroid-resistant focal segmental glomerulosclerosis. North America Nephrotic Syndrome Study Group. Kidney Int. 1999;56:2220-2226.
9. Berg AL, Arnadottir M. ACTH-induced improvement in the nephrotic syndrome in patients with a variety of diagnoses. Nephrol Dial Transplant. 2004;19:1305-1307.
10. Ponticelli C, Passerini P, Salvadori M, et al. A randomized pilot trial comparing methylprednisolone plus a cytotoxic agent versus synthetic adrenocorticotropic hormone in idiopathic membranous nephropathy. Am J Kidney Dis. 2006;47:233-240.
11. Rauen T, Michaelis A, Floege J, Mertens PR. Case series of idiopathic membranous nephropathy with long-term beneficial effects of ACTH peptide 1-24. Clin Nephrol. 2009;71:637-642.
12. Beck LH Jr, Bonegio RG, Lambeau G, et al. M-type phospholipase A2 receptor as target antigen in idiopathic membranous nephropathy. N Engl J Med. 2009;361:11-21.
13. Lindskog A, Ebefors K, Johansson ME, et al. Melanocortin 1 receptor agonists reduce proteinuria. J Am Soc Nephrol. 2010;21:1290-1298.